Κατάλογος ενδεικτικών δημοσιεύσεων του τμήματος Ιατρικής ΑΠΘ σε διεθνή επιστημονικά περιοδικά κατά τα τελευταία 5 έτη.
Interactions between human phagocytes and Candida albicans biofilms alone and in combination with antifungal agents..
J Infect Dis. 201(12), 1941-9.
(2010). Effects of interferon-γ and granulocyte colony-stimulating factor on antifungal activity of human polymorphonuclear neutrophils against Candida albicans grown as biofilms or planktonic cells..
Cytokine. 55(3), 330-4.
(2011). A randomized, single-blinded, vehicle-controlled study of a topical active blend in the treatment of androgenetic alopecia..
Dermatol Ther. 33(4), e13734.
(2020). Tumor cell metabolic reprogramming and hypoxic immunosuppression: driving carcinogenesis to metastatic colonization..
Front Immunol. 14, 1325360.
(2023). Kras-driven intratumoral heterogeneity triggers infiltration of M2 polarized macrophages via the circHIPK3/PTK2 immunosuppressive circuit..
Sci Rep. 11(1), 15455.
(2021). Engineered multifunctional nanocarriers for controlled drug delivery in tumor immunotherapy..
Front Oncol. 12, 1042125.
(2022). Immune Specific and Tumor-Dependent mRNA Vaccines for Cancer Immunotherapy: Reprogramming Clinical Translation into Tumor Editing Therapy..
Pharmaceutics. 16(4),
(2024). Tumor-Infiltrating Dendritic Cells: Decisive Roles in Cancer Immunosurveillance, Immunoediting, and Tumor T Cell Tolerance..
Cells. 11(20),
(2022). Immunoengineering via Chimeric Antigen Receptor-T Cell Therapy: Reprogramming Nanodrug Delivery..
Pharmaceutics. 15(10),
(2023). Real-world data on prognosis and outcome of primary plasma cell leukemia in the era of novel agents: a multicenter national study by the Greek Myeloma Study Group..
Blood Cancer J. 8(3), 31.
(2018). Real-world data on Len/Dex combination at second-line therapy of multiple myeloma: treatment at biochemical relapse is a significant prognostic factor for progression-free survival..
Ann Hematol. 97(9), 1671-1682.
(2018). Lack of survival improvement with novel anti-myeloma agents for patients with multiple myeloma and central nervous system involvement: the Greek Myeloma Study Group experience..
Ann Hematol. 94(12), 2033-42.
(2015). Evaluation of hypochromic erythrocytes in combination with sTfR-F index for predicting response to r-HuEPO in anemic patients with multiple myeloma..
Lab Hematol. 12(1), 47-54.
(2006). Carboplatin plus pemetrexed as first-line treatment of patients with malignant pleural mesothelioma: a phase II study..
Clin Lung Cancer. 11(1), 30-5.
(2010). Subcutaneous and total fat at L4-L5 and subcutaneous, visceral and total fat at L3-L4 are important contributors of fasting and postprandial adiponectin levels..
Endocr Res. 40(3), 127-32.
(2015). Body fat distribution by anthropometric and MRI-based techniques in relation to insulin secretion and action in men with diabetes..
Minerva Endocrinol. 39(2), 107-17.
(2014). Association between the heme oxygenase-1 promoter polymorphism and renal transplantation outcome in Greece..
Transplant Proc. 42(7), 2479-85.
(2010). Genotype and allele frequencies of heme oxygenase-1 promoter region in a Greek cohort..
Chin Med J (Engl). 124(20), 3408-11.
(2011). A case-control study on the rs3130932 single nucleotide polymorphism in the OCT4B translation initiation codon in association with cancer state..
Eur J Cancer Prev. 20(3), 248-51.
(2011). Dexamethasone, rituximab, and cyclophosphamide as primary treatment of Waldenström macroglobulinemia: final analysis of a phase 2 study..
Blood. 126(11), 1392-4.
(2015). Renal outcomes in patients with AL amyloidosis: Prognostic factors, renal response and the impact of therapy..
Am J Hematol. 92(7), 632-639.
(2017). Evaluation of minimal residual disease using next-generation flow cytometry in patients with AL amyloidosis..
Blood Cancer J. 8(5), 46.
(2018). Growth differentiation factor-15 is a new biomarker for survival and renal outcomes in light chain amyloidosis..
Blood. 131(14), 1568-1575.
(2018). Evaluation of the Revised International Staging System in an independent cohort of unselected patients with multiple myeloma..
Haematologica. 102(3), 593-599.
(2017).
(2015).